메뉴 건너뛰기




Volumn 12, Issue 12, 2014, Pages 2102-2112

Apoptotic effects of platelet factor VIII on megakaryopoiesis: Implications for a modified human FVIII for platelet-based gene therapy

Author keywords

Apoptosis; Blood platelets; Coagulation factor VIII; Gene therapy; Megakaryocytes

Indexed keywords

BLOOD CLOTTING FACTOR 8; HEMOSTATIC AGENT; LENTIVIRUS VECTOR;

EID: 84916619967     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12749     Document Type: Article
Times cited : (20)

References (37)
  • 1
    • 0033200188 scopus 로고    scopus 로고
    • Advances toward gene therapy for hemophilia at the millennium
    • Kaufman RJ. Advances toward gene therapy for hemophilia at the millennium. Hum Gene Ther 1999; 10: 2091-107.
    • (1999) Hum Gene Ther , vol.10 , pp. 2091-2107
    • Kaufman, R.J.1
  • 2
    • 84916617201 scopus 로고
    • Pilot study of hemophilia treatment in the US National Heart, Lung and Blood Resources Studies
    • Department of Health and Human Services: National Heart LaBRS. Pilot study of hemophilia treatment in the US National Heart, Lung and Blood Resources Studies Vol. 3. 1972.
    • (1972) National Heart LaBRS. , vol.3
  • 3
    • 0028266130 scopus 로고
    • A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group
    • Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G 3rd, Lee M. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group. Blood 1994; 83: 2428-35.
    • (1994) Blood , vol.83 , pp. 2428-2435
    • Bray, G.L.1    Gomperts, E.D.2    Courter, S.3    Gruppo, R.4    Gordon, E.M.5    Manco-Johnson, M.6    Shapiro, A.7    Scheibel, E.8    White, G.9    Lee, M.10
  • 4
    • 0027473752 scopus 로고
    • Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group
    • Lusher JM, Arkin S, Abildgaard CF, Schwartz RS. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med 1993; 328: 453-9.
    • (1993) N Engl J Med , vol.328 , pp. 453-459
    • Lusher, J.M.1    Arkin, S.2    Abildgaard, C.F.3    Schwartz, R.S.4
  • 6
    • 84897562467 scopus 로고    scopus 로고
    • Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
    • Mancuso ME, Mannucci PM. Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias. Drug Des Devel Ther 2014; 8: 365-71.
    • (2014) Drug Des Devel Ther , vol.8 , pp. 365-371
    • Mancuso, M.E.1    Mannucci, P.M.2
  • 7
    • 84898028710 scopus 로고    scopus 로고
    • Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A
    • Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J. Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. J Thromb Haemost 2014; 12: 488-96.
    • (2014) J Thromb Haemost , vol.12 , pp. 488-496
    • Coyle, T.E.1    Reding, M.T.2    Lin, J.C.3    Michaels, L.A.4    Shah, A.5    Powell, J.6
  • 8
    • 0038383605 scopus 로고    scopus 로고
    • The epidemiology of inhibitors in haemophilia A: a systematic review
    • Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003; 9: 418-35.
    • (2003) Haemophilia , vol.9 , pp. 418-435
    • Wight, J.1    Paisley, S.2
  • 9
    • 84905861716 scopus 로고    scopus 로고
    • Promising coagulation factor VIII bypassing strategies for patients with haemophilia A
    • Duan X, Tang M, Zhang J, Yu H, Xu R. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A. Blood Coagul Fibrinolysis 2014; 25: 539-52.
    • (2014) Blood Coagul Fibrinolysis , vol.25 , pp. 539-552
    • Duan, X.1    Tang, M.2    Zhang, J.3    Yu, H.4    Xu, R.5
  • 13
    • 45549109031 scopus 로고    scopus 로고
    • Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors
    • Gewirtz J, Thornton MA, Rauova L, Poncz M. Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors. J Thromb Haemost 2008; 6: 1160-6.
    • (2008) J Thromb Haemost , vol.6 , pp. 1160-1166
    • Gewirtz, J.1    Thornton, M.A.2    Rauova, L.3    Poncz, M.4
  • 14
    • 84905667071 scopus 로고    scopus 로고
    • In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low MOI
    • Schroeder JA, Chen Y, Fang J, Wilcox DA, Shi Q. In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low MOI. J Thromb Haemost 2014; 12: 1283-93.
    • (2014) J Thromb Haemost , vol.12 , pp. 1283-1293
    • Schroeder, J.A.1    Chen, Y.2    Fang, J.3    Wilcox, D.A.4    Shi, Q.5
  • 15
    • 51649110213 scopus 로고    scopus 로고
    • Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots
    • Neyman M, Gewirtz J, Poncz M. Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots. Blood 2008; 112: 1101-8.
    • (2008) Blood , vol.112 , pp. 1101-1108
    • Neyman, M.1    Gewirtz, J.2    Poncz, M.3
  • 16
    • 84878263829 scopus 로고    scopus 로고
    • Harnessing the platelet signaling network to produce an optimal hemostatic response
    • Brass LF, Tomaiuolo M, Stalker TJ. Harnessing the platelet signaling network to produce an optimal hemostatic response. Hematol Oncol Clin North Am 2013; 27: 381-409.
    • (2013) Hematol Oncol Clin North Am , vol.27 , pp. 381-409
    • Brass, L.F.1    Tomaiuolo, M.2    Stalker, T.J.3
  • 23
    • 0037111573 scopus 로고    scopus 로고
    • Identification of distal regulatory regions in the human alpha IIb gene locus necessary for consistent, high-level megakaryocyte expression
    • Thornton MA, Zhang C, Kowalska MA, Poncz M. Identification of distal regulatory regions in the human alpha IIb gene locus necessary for consistent, high-level megakaryocyte expression. Blood 2002; 100: 3588-96.
    • (2002) Blood , vol.100 , pp. 3588-3596
    • Thornton, M.A.1    Zhang, C.2    Kowalska, M.A.3    Poncz, M.4
  • 24
    • 0141595894 scopus 로고    scopus 로고
    • Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy
    • Celi A, Merrill-Skoloff G, Gross P, Falati S, Sim DS, Flaumenhaft R, Furie BC, Furie B. Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy. J Thromb Haemost 2003; 1: 60-8.
    • (2003) J Thromb Haemost , vol.1 , pp. 60-68
    • Celi, A.1    Merrill-Skoloff, G.2    Gross, P.3    Falati, S.4    Sim, D.S.5    Flaumenhaft, R.6    Furie, B.C.7    Furie, B.8
  • 25
    • 0027237331 scopus 로고
    • Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production
    • Lynch CM, Israel DI, Kaufman RJ, Miller AD. Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Hum Gene Ther 1993; 4: 259-72.
    • (1993) Hum Gene Ther , vol.4 , pp. 259-272
    • Lynch, C.M.1    Israel, D.I.2    Kaufman, R.J.3    Miller, A.D.4
  • 28
    • 78649989718 scopus 로고    scopus 로고
    • Animal Models Subcommittee of the Scientific and Standardization Committee of the ISTH. Towards a standardization of the murine tail bleeding model
    • Greene TK, Schiviz A, Hoellriegl W, Poncz M, Muchitsch EM. Animal Models Subcommittee of the Scientific and Standardization Committee of the ISTH. Towards a standardization of the murine tail bleeding model. J Thromb Haemost 2010; 8: 2820-2.
    • (2010) J Thromb Haemost , vol.8 , pp. 2820-2822
    • Greene, T.K.1    Schiviz, A.2    Hoellriegl, W.3    Poncz, M.4    Muchitsch, E.M.5
  • 29
    • 1842852173 scopus 로고    scopus 로고
    • Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters
    • Wiwanitkit V. Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost 2004; 10: 175-8.
    • (2004) Clin Appl Thromb Hemost , vol.10 , pp. 175-178
    • Wiwanitkit, V.1
  • 31
    • 0842277797 scopus 로고    scopus 로고
    • Bleeding complications after hematopoietic stem cell transplantation
    • Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol 2004; 41: 93-100.
    • (2004) Semin Hematol , vol.41 , pp. 93-100
    • Pihusch, M.1
  • 32
    • 0037325163 scopus 로고    scopus 로고
    • Structure and function of the factor VIII gene and protein
    • Thompson AR. Structure and function of the factor VIII gene and protein. Semin Thromb Hemost 2003; 29: 11-22.
    • (2003) Semin Thromb Hemost , vol.29 , pp. 11-22
    • Thompson, A.R.1
  • 33
    • 20444417088 scopus 로고    scopus 로고
    • Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII
    • Yarovoi H, Nurden AT, Montgomery RR, Nurden P, Poncz M. Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII. Blood 2005; 105: 4674-6.
    • (2005) Blood , vol.105 , pp. 4674-4676
    • Yarovoi, H.1    Nurden, A.T.2    Montgomery, R.R.3    Nurden, P.4    Poncz, M.5
  • 34
    • 0030664471 scopus 로고    scopus 로고
    • Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa
    • Pipe SW, Kaufman RJ. Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa. Proc Natl Acad Sci USA 1997; 94: 11851-6.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 11851-11856
    • Pipe, S.W.1    Kaufman, R.J.2
  • 35
    • 0022049305 scopus 로고
    • Biochemistry of alpha granule proteins
    • Holt JC, Niewiarowski S. Biochemistry of alpha granule proteins. Semin Hematol 1985; 22: 151-63.
    • (1985) Semin Hematol , vol.22 , pp. 151-163
    • Holt, J.C.1    Niewiarowski, S.2
  • 37
    • 0025743588 scopus 로고
    • The platelet open canalicular system: a final common pathway
    • Escolar G, White JG. The platelet open canalicular system: a final common pathway. Blood Cells 1991; 17: 467-85.
    • (1991) Blood Cells , vol.17 , pp. 467-485
    • Escolar, G.1    White, J.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.